Stay updated on MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page.

Latest updates to the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.3 was added to the Record History, signaling a new version posting. The items listed under deletions—'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'—were removed.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page history shows a new revision label Revision: v3.3.2 added and the prior Revision: v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedA new site revision entry (Revision: v3.3.1) was added and the previous revision (Revision: v3.2.0) was removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedNotice about government funding lapse and potential data delays was removed from the page.SummaryDifference0.8%

- Check55 days agoChange DetectedA new history entry dated 2022-06-13 was added, updating the Study Status and referencing prior Recruitment Status changes in the record.SummaryDifference0.1%

- Check84 days agoChange Detected- Added a government operating status notice and a link to official sources for NIH Clinical Center status. - Updated version to v3.2.0 and removed reference to v3.1.0.SummaryDifference13%

Stay in the know with updates to MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page.